Alteminostat is a novel pan-HDAC inhibitor with significant in vitro growth inhibition of multiple myeloma cell lines, especially in reducing the secretion of interleukin 6, which is associated with the proliferation of myeloma cells [88]. The gene discussed is IL6; the disease is plasma cell myeloma.